Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The treatment of acute exacerbation of bronchiectasis requires comprehensive treatment, and antibacterial drug therapy is the key. The study is a multicenter, randomized, evaluator-blinded, levofloxacin parallel-controlled clinical study designed to evaluate the efficacy and safety of sitafloxacin in the treatment of acute exacerbations of bronchiectasis in adults.
Epistemonikos ID: 47fcd6a52e5a70c267a1e5796729cf8ddd954993
First added on: May 13, 2024